Pericardial involvement at diagnosis in pediatric Hodgkin lymphoma patients

Pediatric Blood and Cancer

Volumn 49, Issue 5, 2007, Pages 666-671

  Bashir, Hamid ^a   Hudson, Melissa M ^b,c   Kaste, Sue C ^a,b   Howard, Scott C ^b,c   Krasin, Matthew ^a,b   Metzger, Monika L ^b,c  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^c UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

Hodgkin lymphoma; Pericardial effusion; Pericardial metastasis; Tamponade

Indexed keywords

BLEOMYCIN; CHLORMETHINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE;

ADOLESCENT; CANCER INCIDENCE; CHILD; CHILDHOOD CANCER; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; DYSPNEA; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART FUNCTION; HEART VENTRICLE HYPERTROPHY; HEMODYNAMIC MONITORING; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDIASTINUM TUMOR; NODULAR SCLEROSIS HODGKIN LYMPHOMA; OUTCOMES RESEARCH; OVERALL SURVIVAL; PERICARDIAL EFFUSION; PERICARDIUM; PRIORITY JOURNAL; RELAPSE; REVIEW; SALVAGE THERAPY; SUPERIOR CAVA VEIN SYNDROME; SYMPTOMATOLOGY; TREATMENT OUTCOME; ARTICLE; HEART TUMOR; INFANT; METASTASIS; MORTALITY; PATHOLOGY; PRESCHOOL CHILD; RECURRENT DISEASE; RETROSPECTIVE STUDY; SURVIVAL;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; HEART NEOPLASMS; HODGKIN DISEASE; HUMANS; INFANT; MALE; NEOPLASM METASTASIS; PERICARDIAL EFFUSION; PERICARDIUM; RECURRENCE; RETROSPECTIVE STUDIES; SALVAGE THERAPY; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 35148824586     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.20993     Document Type: Review

References (26)

1. Chiles C, Woodard PK, Gutierrez FR, et al. Metastatic involvement of the heart and pericardium: CT and MR imaging Involvement of the heart and pericardium in the malignant lymphomas. Radiographics 2001;21:439-449.
2. Hancock EW. Neoplastic pericardial disease. Cardiol Clin 1990;8: 673-682.
3. Schoen FJ, Berger BM, Guerina NG. Cardiac effects of noncardiac neoplasms. Cardiol Clin 1984;2:657-670.
4. Celermajer DS, Boyer MJ, Bailey BP, et al. Pericardiocentesis for symptomatic malignant pericardial effusion: A study of 36 patients. Med J Aust 1991;154:19-22.
5. Shepherd FA. Malignant pericardial effusion. Curr Opin Oncol 1997;9:170-174.
6. Carbone PP, Kaplan HS, Musshoff K, et al. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 1971;31:1860-1861.
7. Donaldson SS, Hudson MM, Lamborn KR, et al. VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: Results of a prospective clinical trial. J Clin Oncol 2002;20:3081-3087.
8. Friedmann AM, Hudson MM, Weinstein HJ, et al. Treatment of unfavorable childhood Hodgkin's disease with VEPA and low-dose, involved-field radiation. J Clin Oncol 2002;20:3088-3094.
9. Hudson MM, Krasin M, Link MP, et al. Risk-adapted, combined-modality therapy with VAMP/COP and response-based, involved-field radiation for unfavorable pediatric Hodgkin's disease. J Clin Oncol 2004;22:4541-4550.
10. DeCamp MM, Jr. Mentzer SJ, Swanson SJ, et al. Malignant effusive disease of the pleura and pericardium. Chest 1997;112:291S-295S.
11. Galli M, Politi A, Jemoli R, et al. Transcatheter management of cardiac and pericardial metastatic involvement. G Ital Cardiol 1998;28:687-690.
12. Lam KY, Dickens P, Chan AC. Tumors of the heart. A 20-year experience with a review of 12,485 consecutive autopsies. Arch Pathol Lab Med 1993;117:1027-1031.
13. Silvestri F, Bussani R, Pavletic N, et al. Metastases of the heart and pericardium. G Ital Cardiol 1997;27:1252-1255.
14. Theologides A. Neoplastic cardiac tamponade. Semin Oncol 1978;5:181-192.
15. Petersen CD, Robinson WA, Kurnick JE. Involvement of the heart and pericardium in the malignant lymphomas. Am J Med Sci 1976;272:161-165.
16. Barbetakis NG, Vassiliadis M, Krikeli M, et al. Cardiac tamponade secondary to metastasis from adenocarcinoma of the parotid gland. World J Surg Oncol 2003;1:20.
17. Memon AQ, Xavier L. Malignant lymphoma of the heart. Featured echocardiogram and case report. Cardiol Rev 2002;10:323-325.
18. Meng Q, Lai H, Lima J, et al. Echocardiographic and pathological characteristics of cardiac metastasis in patients with lymphoma. Oncol Rep 2002;9:85-88.
19. Maher EA, Shepherd FA, Todd TJ. Pericardial sclerosis as the primary management of malignant pericardial effusion and cardiac tamponade. J Thorac Cardiovasc Surg 1996;112:637-643.
20. Fiocco M, Krasna MJ. The management of malignant pleural and pericardial effusions. Hematol Oncol Clin North Am 1997;11: 253-265.
21. Diehl LF, Hopper KD, Giguere J, et al. The pattern of intrathoracic Hodgkin's disease assessed by computed tomography. J Clin Oncol 1991;9:438-443.
22. Dieckmann K, Potter R, Hofmann J, et al. Does bulky disease at diagnosis influence outcome in childhood Hodgkin's disease and require higher radiation doses? Results from the German-Austrian Pediatric Multicenter Trial DAL-HD-90. Int J Radiat Oncol Biol Phys 2003;56:644-652.
23. Dawson WB, Mayo JR, Muller NL. Computed tomography of cardiac and pericardial tumors. Can Assoc Radiol J 1990;41:270-275.
24. Roberts WC, Glancy DL, DeVita VT Jr. Heart in malignant lymphoma (Hodgkin's disease, lymphosarcoma, reticulum cell sarcoma and mycosis fungoides). A study of 196 autopsy cases. Am J Cardiol 1968;22:85-107.
25. Sagrista-Sauleda J, Merce J, Permanyer-Miralda G, et al. Clinical clues to the causes of large pericardial effusions. Am J Med 2000;109:95-101.
26. Millaire A, Wurtz A, de GP, et al. Malignant pericardial effusions: Usefulness of pericardioscopy. Am Heart J 1992;124:1030-1034.